Moedas / NRIX
NRIX: Nurix Therapeutics Inc
11.88
USD
0.16
(1.33%)
A taxa do NRIX para hoje mudou para -1.33%. Paralelamente, o preço mais baixo no mercado atingiu 11.78 e o mais alto foi 12.33.
Veja a dinâmica do par de moedas Nurix Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NRIX Notícias
- Investing Nurix therapeutics (NRIX) CSO Hansen sells $51k in stock
- Investing Nurix Therapeutics’ ring sells $46k in stock to cover tax obligations
- Investing Nurix Therapeutics CFO van Houte sells $51,695 in shares
- Investing Morgan Stanley lowers Nurix stock price target to $16 on higher spend
- TipRanks Top 3 Trending Stocks, According to Analysts – 7/11/2025 - TipRanks.com
- Investing Stifel maintains Buy rating on Nurix stock, sees $4.5B peak sales potential
- Investing Nurix stock price target lowered to $26 by UBS on increased OpEx
- Investing Goldman Sachs initiates Nurix stock with Buy rating, $182 price target
- Investing Stifel reiterates Buy rating on Nurix stock, sees $4.5B peak sales potential
- Investing Nurix earnings beat by $0.19, revenue topped estimates
- Investing Nurix Therapeutics beats quarterly expectations on strong collaboration revenue
- Investing Nurix stock maintains Buy rating at H.C. Wainwright on positive BTK degrader data
- Seeking Alpha Tracking Baker Brothers Portfolio – Q1 2025 Update
- Investing Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Investing Nurix stock price target reiterated at $30 by UBS on positive trial data
- Investing Nurix stock price target raised to $28 from $27 at RBC Capital
- Investing Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chroni
- Investing Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congr
- Investing Stifel analysts maintain Buy rating on Nurix stock after SNY deal
- Investing UnitedHealth, Biontech lead Monday’s market cap stock movers
- Investing Sanofi extends license option with Nurix’s STAT6 program
- Benzinga Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout - Nurix Therapeutics (NASDAQ:NRIX), Blueprint Medicines (NASDAQ:BPMC), Sanofi (NASDAQ:SNY)
- Investing Nurix secures additional $15 million from Sanofi license deal
- Investing Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
Faixa diária
11.78
12.33
Faixa anual
8.18
29.56
- Fechamento anterior
- 11.89
- Open
- 12.04
- Bid
- 11.88
- Ask
- 12.18
- Low
- 11.78
- High
- 12.33
- Volume
- 2.183 K
- Mudança diária
- -1.33%
- Mudança mensal
- 4.30%
- Mudança de 6 meses
- -38.79%
- Mudança anual
- -46.00%
31 julho, quinta-feira
11:30
USD
- Atu.
- Projeç.
- Prév.
- 47.999 mil
11:30
USD
- Atu.
- Projeç.
- -68.3%
- Prév.
- -1.6%
12:30
USD
- Atu.
- Projeç.
- 0.4%
- Prév.
- 0.2%
12:30
USD
- Atu.
- Projeç.
- 2.6%
- Prév.
- 2.7%
12:30
USD
- Atu.
- Projeç.
- 0.2%
- Prév.
- 0.1%
12:30
USD
- Atu.
- Projeç.
- 2.3%
- Prév.
- 2.3%
12:30
USD
- Atu.
- Projeç.
- 0.2%
- Prév.
- -0.1%
12:30
USD
- Atu.
- Projeç.
- 0.7%
- Prév.
- -0.4%
12:30
USD
- Atu.
- Projeç.
- 0.0%
- Prév.
- -0.3%
12:30
USD
- Atu.
- Projeç.
- 0.9%
- Prév.
- 0.9%
12:30
USD
- Atu.
- Projeç.
- 1.0%
- Prév.
- 1.2%
12:30
USD
- Atu.
- Projeç.
- 0.7%
- Prév.
- 0.8%
12:30
USD
- Atu.
- Projeç.
- 224 mil
- Prév.
- 217 mil
12:30
USD
- Atu.
- Projeç.
- 1.966 milh
- Prév.
- 1.955 milh
12:30
USD
- Atu.
- Projeç.
- 222.299 mil
- Prév.
- 224.500 mil
13:45
USD
- Atu.
- Projeç.
- 42.4
- Prév.
- 40.4
14:00
USD
- Atu.
- Projeç.
- 2.3%
- Prév.
- 2.0%
14:30
USD
- Atu.
- Projeç.
- 2 bilh
- Prév.
- 23 bilh
15:30
USD
- Atu.
- Projeç.
- Prév.
- 4.245%
15:30
USD
- Atu.
- Projeç.
- Prév.
- 4.265%